Variation in performance of candidate surgical quality measures for muscle-invasive bladder cancer by hospital type
- PMID: 24447637
- PMCID: PMC4472465
- DOI: 10.1111/bju.12638
Variation in performance of candidate surgical quality measures for muscle-invasive bladder cancer by hospital type
Abstract
Objective: To test the association between hospital type and performance of candidate quality measures for treatment of muscle-invasive bladder cancer (MIBC) using a large national tumour registry. Proposed quality measures include receipt of neoadjuvant chemotherapy, timely treatment, adequate lymph node dissection, and continent urinary diversion.
Patients and methods: Using the National Cancer Database, patients with stage ≥II urothelial carcinoma treated with radical cystectomy (RC) from 2003 to 2010 were identified. Hospitals were grouped by type and annual RC volume: community, comprehensive low volume (CLV), comprehensive high volume (CHV), academic low volume (ALV), and academic high volume (AHV) groups. Logistic regression models were used to test the association between hospital group and performance of quality measures, adjusting for year, demographic, and clinical/pathological characteristics; generalised estimating equations were fitted to the models to adjust for clustering at the hospital level.
Results: In all, 23 279 patients underwent RC at community (12.4%), comprehensive (CLV 38%, CHV 5%), and academic (ALV 17%, AHV 28%) hospitals. While only 0.8% (175) of patients met all four quality criteria, 61% of patients treated at AHV hospitals met two or more quality metric indicators compared with ALV (45%), CHV (44%), CLV (38%), and community (37%) hospitals (P < 0.001). After adjustment, patients were more likely to receive two or more quality measures when treated at AHV (odds ratio [OR] 2.4, confidence interval [CI] 2.0-2.9), ALV (OR 1.3, CI 1.1-1.6), and CHV (OR 1.3, CI 1.03-1.7) hospitals compared with community hospitals.
Conclusions: Patients undergoing RC at AHV hospitals were more likely to meet quality criteria. However, performance remains low across hospital types, highlighting the opportunity to improve quality of care for MIBC.
Keywords: bladder cancer; hospital type; quality measures; radical cystectomy; surgical volume.
© 2014 The Authors. BJU International © 2014 BJU International.
Conflict of interest statement
No financial disclosures or conflicts of interest.
Figures


Comment in
-
Re: Variation in Performance of Candidate Surgical Quality Measures for Muscle-Invasive Bladder Cancer by Hospital Type.J Urol. 2016 Jun;195(6):1721-2. doi: 10.1016/j.juro.2016.03.025. Epub 2016 Mar 19. J Urol. 2016. PMID: 27191066 No abstract available.
Similar articles
-
Delays in radical cystectomy for muscle-invasive bladder cancer.Cancer. 2019 Jun 15;125(12):2011-2017. doi: 10.1002/cncr.32048. Epub 2019 Mar 6. Cancer. 2019. PMID: 30840335
-
Variations in pelvic lymph node dissection in invasive bladder cancer: A Dutch nationwide population-based study during centralization of care.Urol Oncol. 2016 Dec;34(12):532.e7-532.e12. doi: 10.1016/j.urolonc.2016.06.018. Epub 2016 Aug 2. Urol Oncol. 2016. PMID: 27491835
-
Associations Between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer.Urology. 2018 Apr;114:87-94. doi: 10.1016/j.urology.2017.12.014. Epub 2018 Jan 2. Urology. 2018. PMID: 29305205
-
Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.Cochrane Database Syst Rev. 2019 May 14;5(5):CD013336. doi: 10.1002/14651858.CD013336. Cochrane Database Syst Rev. 2019. PMID: 31111956 Free PMC article.
-
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.Eur Urol. 2013 Jan;63(1):45-57. doi: 10.1016/j.eururo.2012.08.009. Epub 2012 Aug 14. Eur Urol. 2013. PMID: 22917985 Review.
Cited by
-
External validation of current quality care metrics after radical nephroureterectomy.BJU Int. 2025 Aug;136(2):261-270. doi: 10.1111/bju.16741. Epub 2025 Apr 20. BJU Int. 2025. PMID: 40254784 Free PMC article.
-
Meta-analysis of microRNAs as biomarkers for muscle-invasive bladder cancer.Biomed Rep. 2016 Aug;5(2):159-164. doi: 10.3892/br.2016.705. Epub 2016 Jun 23. Biomed Rep. 2016. PMID: 27446534 Free PMC article.
-
NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer.J Cancer. 2017 Mar 7;8(5):852-860. doi: 10.7150/jca.17845. eCollection 2017. J Cancer. 2017. PMID: 28382148 Free PMC article.
-
Robot-assisted brachytherapy of the bladder with long distance support using video conferencing.J Contemp Brachytherapy. 2017 Aug;9(4):375-382. doi: 10.5114/jcb.2017.69548. Epub 2017 Aug 30. J Contemp Brachytherapy. 2017. PMID: 28951758 Free PMC article.
-
OPEN RADICAL CYSTECTOMY: SINGLE CENTER RESULTS AND OUTCOMES IN THE LAST FIVE YEARS.Acta Clin Croat. 2023 Jul;62(Suppl2):21-27. doi: 10.20471/acc.2023.62.s2.3. Acta Clin Croat. 2023. PMID: 38966027 Free PMC article.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: a cancer journal for clinicians. 2013 Jan;63:11–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous